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Non-adherence to self-management poses a serious risk to diabetes complications. Digital behavioural 
change interventions have the potential to provide education and motivate users to regularly engage 
with self-management of diabetes. This paper describes the development of My Care Hub mobile 
phone application (app) aimed at supporting self-management in people with type 1 or type 2 diabetes. 
the development of My care Hub involved a comprehensive process of healthy behavioural change 
identification, end users’ needs, expert consensus, data security and privacy considerations. The app 
translation was a highly iterative process accompanied by usability testing and design modification. 
The app development process included: (1) behaviour change strategy selection; (2) users’ involvement; 
(3) expert advisory involvement; (4) data security and privacy considerations; (5) design creation and 
output translation into a smartphone app and (6) two usability testings of the app prototype version. 
the app features include self-management activities documentation, analytics, personalized and 
generalized messages for diabetes self-management as well as carbohydrate components of common 
foods in Australia. Twelve respondents provided feedback on the usability of the app. Initially, a 
simplification of the documentation features of the app was identified as a need to improve usability. 
Overall, results indicated good user satisfaction rate.
More than 1.1 million Australians have type 1 (12%) and type 2 (85%) diabetes1. Poorly controlled diabetes 
increases the risk of chronic complications2. Diabetes self-management education (DSME) and support are 
effective interventions to assist patients navigate through decision making processes for participation in 
self-management activities necessary for improved glycemic control3 and reduce the risk of developing complica-
tions4. Self-management support could be educational, behavioural, psychosocial or clinical5. Providing ongoing 
support to patients could mitigate disease related distress, improve adherence to recommended self-management 
activities and consequently enhance health outcomes5,6, but this practice has proven difficult in a real-world con-
text7. Provision of self-management support through the use of smartphone may help address health system level 
limiters which impact negatively on the frequency and quality of self-management support patient receives. Such 
limitations include time constraints, limited access to care providers8 and partial cost reimbursement by third 
party health insurance9.
Smart phone is a ubiquitous technological device with more than 2 billion users worldwide10, and over 16% of 
6 billion mobile subscriptions are smartphone subscriptions11. In Australia, the growth in smartphone usage has 
been sporadic, with approximately 84% smartphone users among the entire population of mobile phone users in 
2018, which is an increase from 74% in 201412. Most smart phone functionalities are aided by apps (software that 
are designed to run on smartphones), which could complement highly developed health care technologies and 
serve as supporting tools in many chronic disease management13. Various apps have been developed to enhance 
self-management of diabetes14–18. However, most apps have no reference to health behavioral change models or 
scientific evidence-based theories14,15,17. Additionally, considerations of target users’ preferences14,15, and data 
privacy input16,17 are minimal. Furthermore, some lack educational information which is a crucial component 
of diabetes care, to foster coping skills for ongoing self-management in patients and improved health (glycemic) 
outcomes17,18.
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objective
Emerging evidence support the use of smartphone apps for diabetes self-management14,15,18. However, there 
remains paucity of information in relation to the description of the development processes and design of smart-
phone apps interventions, leaving unanswered questions about how to productively leverage apps for diabetes 
self-management19. Adequate description of the development of interventions could decrease waste in health 
research and enhance better organized synthesis of study results19,20. Vivid explanation of study process will 
promote wider dissemination of research findings and improve the rigour and quality control of published 
research21. In addition, explicit reporting of intervention development can allow external scrutiny of its plausibil-
ity when later used in trials and help evaluators and policy makers decide which context to prioritize for future 
replication22.
On the other hand, assessing usability occupies a central part of app development23. A well designed app 
with high usability positively influences users’ engagement (re-use rates)24 Conversely, poor usability is associ-
ated with low effectiveness and engagement24,25. To the best of the authors’ knowledge, there is no published full 
report of the systematic development of a diabetes smartphone app targeting Australian population before use 
in a full trial. Therefore, this paper reports a full description of the development and usability testing process of 
an app named “My Care Hub” prior to use in a pilot trial. My Care Hub was developed as an app to best meet the 
needs of type 1 and type 2 diabetes patients in the provision of preferred features and diabetes educational con-
tents which could foster incremental knowledge gain, self-efficacy and motivate patients to actively engage with 
self-management activities.
Methods
An initial systematic review19 by the authors highlighted the importance of six essential factors that needed 
consideration in the diabetes app development before actual use in a Randomized Controlled Trial (RCT). 
Specifically, the factors included involvement of users and clinical experts, health behavioural change theory 
employed, data security and privacy considerations, and pilot testing19. In practice, these steps overlap and are 
iterative. Herein, we describe how these steps were considered in the development of My Care Hub. The process 
of pilot testing is excluded because it is beyond the scope of the present paper. Additionally, this paper describes 
the features and functionalities available in My Care Hub and the usability testing of its prototype. All activities 
conducted during the pre-development, development and testing stage of the app are described.
ethical consideration
This study was approved by the James cook University Human Research Ethics Committee (H7087). Informed 
consent was obtained from all participants involved in the usability testing of My Care Hub. All methods were 
performed in accordance with the relevant guidelines and regulations.
Stage 1: Pre-development. Users’ involvement. A user centered design process was utilised in the devel-
opment of My Care Hub. An iterative process addressing people’s needs and the enabling infrastructure to meet 
those needs constitute the central focus of a user centered design approach26. People with type 1 or type 2 diabetes 
were the primary target users of My Care Hub, hence their involvement in the development process, in order to 
gather information and ideas for appropriate design and educational content of the app. We performed a need 
analysis study among a multinational audience of people with type 1 or type 2 diabetes using a mixed methods 
study design27. The study elucidated diabetes patients’ app feature preferences and explored their recommenda-
tions for inclusion to promote engagement with My Care Hub diabetes app. The result indicated that both patient 
groups desired apps that featured documentation (blood glucose and physical exercise), advisory information 
(educational), analytics (view trends in behavioural and health data indicators), reminders (with actionable noti-
fications) and food nutritional database. Furthermore, patients desired educational information on approaches to 
problem solving when blood glucose data were out of the clinically recommended range. Basic guideline informa-
tion for diabetes self-management was perceived to be highly beneficial. Full details of the findings of the needs 
analysis study have been published27.
Health behavioural change theory. Maximizing the potential efficacy of health behavioral change 
interventions in humans requires an understanding of the theoretical models or mechanisms that under-
pin such behavioral changes28. An extensive literature search of behavioural change theories29 was adopted 
to make informed decision in the development of My Care Hub. This provided the opportunity to identify 
the best interventional techniques (and the underlying theories) that are likely to be effective in a diabetes 
self-management app. The first technique considered was self-monitoring; an important intervention that fos-
ters adherence to self-management and driven by self-efficacy construct of the social cognitive theory30,31. 
Self-efficacy refers to confidence in a person’s ability to take action required to implement situation specific 
behaviours in order to attain specific goals (health outcomes)32. Self-efficacy forms the “major basis for action”, 
occupies a pivotal regulatory role in the causal structure of self-management and perseverance to continue 
even when barriers are encountered32. Hence, improving self-efficacy through task related activities such as 
self-monitoring increases the confidence and persistence towards accomplishing the task33. On this basis, it 
was decided that My Care Hub should provide users with a platform to create daily entries and monitoring of 
their health behavioral activities.
Although self-monitoring is an important feature in behavioural interventions, patients’ adherence to 
self-monitoring alone is often low, especially when not accompanied by another intervention which could further 
enhance self-efficacy34. High attrition rates when self-monitoring activities are the only intervention features in 
diabetes apps have been reported16,18,35. Therefore, sole-reliance on self-monitoring features in an app may limit 
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its effectiveness and use to only those who are personally motivated to self-monitor regularly. Consequently, it 
was considered important to include other essential interventional features such as provision of information and 
feedback in My Care Hub.
Components of educational information and feedback in health behavioural interventions are best developed 
using Information-Motivation-Behavioural Skills (IMBS) model36,37. The IMBS model has several constructs 
pertaining to patient adherence to recommended health behaviours. Primarily, the self-management informa-
tion needs to be easily actionable in order to enhance optimal care. In addition, the information should provide 
basic knowledge about the relevant medical condition and effective management strategies. Users also need to 
be provided with encouraging and motivational feedback and recommendations in order to boost their confi-
dence and enhance their ability to achieve desired health behavioural changes38,39. Reinforcing healthy behaviour 
significantly improves self-efficacy for participation in self-management activities40 Furthermore, inclusion of 
behavioural skills which ensure patients are provided specific strategies on how to perform the adherence behav-
iours (diabetes self-management activities- e.g. choosing appropriate foods, problem solving for low/high blood 
glucose) are important to enhance effective self-management. Lastly, IMBS model indicates that strategies aimed 
at increasing patients’ knowledge are prerequisites for behavioural change but not sufficient enough to sustain the 
change41. Therefore, such information should be coupled with motivation to increase the possibility of adherence.
The IMBS constructs were employed in the development of three educational information modules embed-
ded in My Care Hub. These modules were: general information on diabetes management, automated feedback in 
response to logged blood glucose and carbohydrate contents of foods. These modules were aimed at improving 
patients’ knowledge, self-efficacy and provide specific directions for fostering patients’ adherence to ongoing 
self-management.
Data security and privacy considerations. Several security features and privacy policies in the design 
and development of mobile health apps42 were followed. Authorization and authentication of users to assess 
the app was controlled, whereby the first user interface after the app download is a login screen. The screen 
requires a user to enter an assigned unique username (email address) and password in order to gain access to the 
app features. Authentication verifies user session handling for future research and ensures that the server is not 
vulnerable to injection attacks43,44. Protection of data transfer from My Care Hub to cloud storage was ensured 
through encryption which makes the data illegible, unusable and indecipherable to unauthorized persons44. My 
Care Hub was built on a proprietary personal health (PHR) platform using Firebase45 and it has no connection or 
interaction with third party health information systems. In accordance with the “Australian Privacy Principle”46, 
the services of an independent legal firm was employed to develop a comprehensive legal document pertaining to 
legal agreement, terms of use and privacy policy. The document describes how My Care Hub manages personal 
information, data collection, usage and storage. The legal document was incorporated into My Care Hub app for 
easy accessibility by users.
Expert advisory group. An expert advisory group comprising diabetes educators, endocrinologists, health 
researchers and app developers worked as a team to make decisions regarding My Care Hub. Implications of the 
users’ needs analysis study findings and effectiveness of identified health behavioural change interventions were 
discussed by the team27. Results were prioritized, adjusted and refined before a final agreement on the selection 
of My Care Hub features, design and content in order to meet the requested needs of users as much as possible.
Stage 2: Design and translation of pre-development output into a smartphone app. Development 
of My Care Hub Prototype. App developers within the eResearch Team at James Cook University (JCU), 
Queensland, Australia developed the prototype. The purpose of the app was to serve as a tool for monitoring 
self-management activities, providing access to information and aiding motivation to engage with diabetes 
self-management. These purpose were adequately met by providing opportunity to users to monitor and track 
their core health behaviours (weight, physical activities and carbohydrate contents of the foods consumed) and 
vitals (blood glucose); and have easy access to three streams of diabetes educational information: (i) an overview 
of diabetes management, (ii) feedback on logged blood glucose data, and (iii) information on carbohydrate con-
tents in foods. To ensure that the app is usable by both types 1 and 2 diabetes patients, the feedback took into 
consideration the different recommended blood glucose values.
Initially, a visual skeletal framework of the app was created and subsequently used to develop the prototype. 
The framework comprised features, educational content, lay out, and interfacing of the app functionalities. The 
app was developed in Java in order to run on Android Platform. The resulting prototype was thoroughly exam-
ined and tested to ensure that all specified requirements were incorporated into the app for optimal functionality.
Features and Functionalities of My Care Hub. My Care Hub contains the following features: selection of type 
of diabetes, My Info, documentation, View insights, Carbs in foods and educational tips. Description of each 
of these features are provided below and a screen shot of the features in My Care Hub are provided in Figs. 1–2.
Type of DM: This feature is displayed after the user has downloaded, installed and registered the app on their 
smart phone. The user is then required to choose the type of diabetes they have (see Fig. 1a) in order to determine 
the type of feedback to be received when blood glucose data are logged.
My Info: This feature gives the user the choice to set up a profile to document their treatment details. Users 
can indicate their treatment specifics such as recommended blood glucose targets (upper and lower), types of 
medication (oral only, oral plus insulin, insulin only or none) and types of blood glucose meter, insulin pump, 
continuous glucose meter, if applicable. Profile set up may also include personal details such as gender and height 
(Fig. 1b).
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Documentation: The home screen of My Care Hub (Fig. 1c), displays all its documentation features for logging 
of self-management activities including blood glucose, weight, physical activities and carbohydrate content of 
foods consumed. The actual date and time of logging is automatically set and users have the option to record the 
activity location. For the blood glucose (BG) interface, the type of BG data measured (either fasting or post hours 
post breakfast, lunch or dinner) can be selected from a drop menu and saved.
View Insights: This analytic feature provides users with graphical display of all data logged through the doc-
umentation features (Fig. 1d). It also takes the average of all data logged into each of the documentation fea-
tures over a period of seven days and displays the mean on the homepage in form of summary feedback. This 
enables patients to visualise trends in lifestyle activities (especially physical activity and carbohydrate content 
of foods) and observe the impact on blood glucose levels over time47, thus fostering the ability to adjust their 
self-management strategy accordingly.
Figure 1. My Care Hub screenshots.
Figure 2. My Care Hub educational modules screen examples.
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Educational modules: My Care Hub comprises three educational modules:
(a) Overview of diabetes management: The app contains textual information on the seven essential 
self-management activities for people with diabetes. These activities predict the following good health outcomes: 
lifestyle modifications (healthy eating and improved physical activity), monitoring of blood sugar, complying with 
medications, good problem-solving skills, healthy coping skills, and risk-reduction behaviours (such as smoking 
cessation and reduction in alcohol intake)48. (Fig. 2a). The messages were designed to be action-oriented, create 
awareness about associated benefits and provide engagement suggestions. The messages were written in plain 
language to enable users find, interpret and act on findings49. Table 1 depicts examples of app messages under 
each of the vital self-management activities.
(b) Feedback: My Care Hub includes an algorithm that provides automated feedback messages in response to 
logged blood glucose (BG) data. It assesses if the logged BG data are within or outside the clinically recommended 
range and provides appropriate encouragement or advice. This feature was founded on relevant evidence-based 
literature and Diabetes Australia recommended BG level guidelines50 for appropriate and accurate feedback. For 
people with type 1 diabetes; 4–8 mmol/L at fasting and <10 mmol/L 2 hours post prandial BG levels were recom-
mended. Fasting levels of 6–8 mmol/L and 2 hours post prandial levels of 6–10 mmol/L were endorsed for people 
with type 2 diabetes.
A range of evidence-based, motivational, health promotional and behavioural skills information were devel-
oped as feedback on BG levels recommended for both type 1 and type 2 diabetes. Decision based system rules 
were programmed into the app to ensure that users receive semi-individualized feedback based on their logged 
data. The system is controlled by the indicated type of diabetes, value of BG (whether within or beyond the clini-
cally recommended range) and the period of BG measurement (either fasting or 2 hours post prandial). Once BG 
data are logged, the app delivers a brief feedback. If the BG is within the clinically recommended range, the app 
delivers messages to encourage the patient to continue with regular self-management. Such messages include: 
“Excellent; BG within target range, continue your medication as prescribed”, and “Excellent, BG within target 
range, continue with healthy eating”). It has been demonstrated that providing motivation and encouragement 
after attaining a goal can enhance self-efficacy40 which in turn, facilitates health behavioural changes in disease 
control51. If the logged BG are outside normal range, the app offers suggestions related to problem solving for low 
or high BG as deemed appropriate. For instance, if logged BG is less than 4 mmol/L, sample feedback includes: 
“BG levels seems too low, this may occur when medication is not balanced with food and physical activities”, and 
“you are at risk of hypoglycemia; treat immediately”. If BG values are extremely aberrant to the normal range 
(over 15 mmol/L), messages such as “if high levels persist and you don’t know why, seek medical attention imme-
diately” are triggered. Messages are unidirectional and displayed using colour labels, where green, orange and red 
indicate “ideal”, “not ideal” and “extremely low or high” BG levels, respectively (Fig. 2b,c)
(c) Carbohydrates in foods: This feature comprises textual information about carbohydrate and calorie com-
ponents of common foods in Australia sourced from the Australian Food, Supplement and Nutrient database 
(AUSNUT 2011–13)52. Some commonly available foods were selected for this database and organised under four 
main groups: fruits and vegetables; eggs and meat; diary; and legumes and grains. Portion sizes and approximate 
Category Message
What is diabetes?
Diabetes results from inherited and/or acquired deficiency in insulin production or by the ineffectiveness of 
the insulin produced.
In a diabetic state, insulin function is impaired, therefore the body needs conscious help to manage blood 
sugar by eating right, exercising, taking medications appropriately and reducing stress.
Health food choices
Stay motivated to eat healthy. When new foods are eaten, testing of blood sugar before and 2 hours after the 
first bite is recommended in order to see the effect of the food on the blood sugar.
Vegetables are rich in fibre, make you comfortably full, have vitamins for healthy immune system and most 
likely not spike your blood sugar level.
Physical activity
Exercise improves bone strength, keeps the heart and blood vessels healthy and lowers insulin resistance.
Exercise does not have to involve the whole day. You can split it up into 10 minutes, 3 times a day at a 
convenient period for you.
If you are on insulin and planning for prolonged exercise, if your blood sugar level is below 6 mmol/L, it is 
advisable to eat an extra carbohydrate.
Medication usage
Some diabetes medicines can lose effectiveness if they are old or stored improperly. For example, insulin 
should not be frozen or exposed to extreme heat.
If you often forget to take your medications, setting a reminder or alert may help you.
Do not inject insulin on moles or scars because it slows absorption rate and limit insulin effectiveness.
Monitoring blood 
glucose
Some of the important times to test blood glucose include before breakfast (fasting), 2 h after a meal, before 
rigorous exercise, before bed, when you are not feeling well.
Regular testing of blood sugar improves confidence to look after diabetes, give a better understanding of the 
impact of food intake, medication, exercise and other factors such as stress and illness on blood glucose.
Reducing the risk of 
complications
Keeping appointment with the eye/foot doctor, endocrinologist and other health care team is a great way to 
detect on time any complication development.
Smoking increases the risk of developing acute and chronic complications in diabetes mellitus.
Keep your foot healthy by checking regularly for any changes, washing daily and wear shoes that fit properly. 
In the occurrence of unexplainable blisters, cuts or openings, it is best to consult your doctor.
Table 1. Examples of app messages.
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carbohydrate and calorie content were provided for each food item. For example, 1 slice (40 g) of whole wheat 
bread contains 20.56 g of carbohydrates and 111 calories. Foods with low glycemic index were displayed in green 
colours as healthier models for consumption by those who have diabetes53 (Fig. 2d).
Functionalities and Features for future research: To facilitate future research, export of the logged data 
into a cloud storage for all documentation features, date and time of log-ins were enabled for downloading as 
comma-separated value files into our database for subsequent statistical analysis. Furthermore, the app platform 
offers analytics of users’ logged data and performance optimization and includes cloud and in-app messaging 
features to allow for push notifications. These features will provide additional educational messages for future 
research.
Stage 3: Usability testing. Usability testing of My Care Hub was done in two stages. (1) Members of the 
public who do not have diabetes were randomly selected for early testing strategy to ascertain the technical per-
formance of the app and to identify any navigation issues when downloaded on various android phones. The app’s 
functionality and aesthetic usability testing by users was over a period of 7 days. Using convenient and snow ball-
ing sampling methods, twelve participants (app testers) were individually contacted and provided with informa-
tion about My Care Hub and the ultimate aim of its development. The primary inclusion criterion was access to an 
android phone since the app was developed on an android platform only. Specific tasks required of the app testers 
included app download and registration; daily log-ins of random numbers into the documentation features (no 
limit was set to the amount of data to be logged into the app); a read through the educational information about 
diabetes self-management embedded in the app; observation of the automated feedback messages in response to 
each logged BG; examination of the graphical outputs of all the documentation features; and general browsing 
of the app. Any data crash or lag time in the app response during launching and usage, screen “swiping”, using 
the slide out key board and apps touch screen buttons were also monitored. Each tester was contacted via email 
and provided with a unique user name, password and app download instruction. Only testers who signed into 
and used the app were provided with a link to the online survey questionnaire items adapted from the mobile 
app rating scale54. Testers were asked to rate the app’s functionality (performance, ease of use, navigation, gestural 
design) and aesthetics (layout, graphics, visual appeal of the analytic display). The results from this first stage of 
usability testing was used to improve the app prototype before the second stage was completed.
(2) The second stage of testing recruited participants who had diabetes from the diabetes center of a tertiary 
hospital in Queensland, Australia, and through snow balling. Participants were asked to use My Care Hub and 
provide feedback. In addition to functionality and aesthetics of the app, they also provided feedback on their sat-
isfaction using measures that included perceived usefulness of the app to motivate participation in, and increase 
awareness of, diabetes self-management, intention to use, perceived ease of use and accuracy of the educational 
components of the app. Furthermore, they were asked if they would recommend the app to people with type 1 or 
type 2 diabetes and give an overall rating of 1–5 with “1 = one of the worst apps I have ever used” and “5 = one of 
the best apps I have ever used”. The usability questions are provided in the Supplementary Information.
Results
Demographic and health characteristics. Of the 12 testers without diabetes, only eight (8) signed into 
the app. In the second stage of testing, 6 individuals with type 1 or type 2 agreed to test the app, but only 4 signed 
in. Time constraint was cited by the 6 people who withdrew from the testing as reason for non-participation. 
Feedback was provided by the remaining 12 participants (8 non diabetes + 4 with diabetes) who downloaded and 
used the app. The mean age of participants was 43.08 ± 14.02 years (range 28–76 years) and 58% of them were 
women. More than 75% were married and had obtained an educational level of first degree or higher. Of the four 
participants who have diabetes, three of them had type 2, one of them was diagnosed less than 5 years ago, while 
the remaining 3 had been diagnosed over 5 years. None of them reported hypoglycemia unawareness. Three of 
the four participants reported that their recommended range of fasting blood glucose was 4 to 7 mmol/L, with 
a post prandial of 5 to 9 mmol/L. The remaining one participant who had type 2 diabetes did not provide any 
information on this.
Usability result. In stage one of testing, all participants but one, were able to easily learn the use of the app 
following instructions provided via email. This one participant expressed an initial difficulty in operating the app 
by providing free text comment in the survey. Locating and learning how to use the documentation features took 
time, hence the suggestion to include a video recording of the instructions in addition to the already developed 
instruction manual for future users. Although, it was only one participant that indicated difficulty in using the 
app, it meant 13% of the participants had potential usability issues in relation to layout and ease of use. Therefore, 
based on the results of the first stage usability testing, minor modifications were made. In the prototype, accessing 
the documentation features required users to tap on a menu bar located on the top left corner of the app’s home-
page (which may not be apparent to users). The current version provides an improvement with an additional 
access via the app’s homepage through direct taping on the icons of the documentation features.
In the second stage of testing using individuals with type 1 or type 2 diabetes, all the four participants were 
able to use the app easily. Across all participants (12), majority were satisfied with the performance of the app in 
terms of how fast the app features and components work (50% chose “perfect/timely response”, 41.7% “mostly 
functional”, 8.3% “app work overall, slow at times”). Several participants were able to navigate between app 
screens and features easily (66.7% “perfectly logical and clear screen flow throughout”, 25% “easy to use”) and felt 
that interactions across all tabs in the app were consistent and spontaneous (41.7% “perfectly consistent and spon-
taneous”, 50% “mostly consistent and spontaneous”). Many participants were satisfied with the arrangement and 
size of icons/contents in the app (66.7% “mostly clear”, 33.4% “professional, simple, clear and logically organised”) 
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and the quality of graphics was high/very high. With regards to the general visual appeal of the app and the ana-
lytic feature, 83.3% participants chose very high/high level of visual appeal for both domains. The app was given 
a five and four star rating by 8.3% and 91.7% respondents respectively.
Among the four participants with diabetes, 75% of them strongly agreed that they saw value in the edu-
cational content of the app as it was relevant and likely to raise awareness of the importance of diabetes 
self-management. 75% strongly agreed that the app is likely to increase motivation of people with diabetes to 
engage in self-management activities. Furthermore, 75% noted that they would recommend My Care Hub to 
people with type 1 or type 2 diabetes and that they can continue to use it if granted continual access to the app.
Discussion
This paper follows the principle of intervention development study report which details “the rationale, decision 
making processes, methods and findings from the inception of the intervention to the usability testing prior 
to full trial or evaluation”55. To the best of the authors’ knowledge, My Care Hub is arguably the first diabetes 
self-management app aimed at Australian population with type 1 or type 2 diabetes to have reported/ documented 
a systematic and transparent approach to its development based on empirical and theoretical framework of health 
behavior change theories, involvement of users and clinical experts, data security and privacy considerations19.
Behavioural theory is critical to the development of health behavioural change interventions56 because inter-
ventions grounded in theory are more effective at modifying behaviour29,57. Health behavioural theories predict 
how applying an intervention will drive change in underlying behavioural mechanisms or technique (mediating 
construct) that will in turn, drive behavioural change (output)29. Majority of currently available diabetes app are 
lacking in health behavioural content19,58 which may be an early indication of the low potential of such apps to 
influence behaviour long term57. My Care Hub is grounded in two major theories of behavioural change: Social 
cognitive theory31 and Information-Motivation-Behavioural Skills model36,37. Diverse constructs were employed 
within these theories; hence, giving My Care Hub the potential for effectiveness when eventually used as an inter-
vention in RCT.
Specific features and educational content in My Care Hub were chosen based on users’ needs and prefer-
ences27. This is an added strength of the app which is often lacking in many health apps that are developed with-
out considering the needs of the end users or guidelines for the management of such diseases59,60. Development 
of an intervention to meet the actual needs and demands of targeted users assures the feasibility of the prod-
uct26. Previous reports show that only few diabetes mobile apps incorporate elements of clinical best practices 
established by diabetes professionals61. Blood glucose level guidelines recommended by Diabetes Australia were 
consulted during the development of feedback messages provided in My Care Hub in order to ensure clinically 
sound information is provided to the patients. Providing relevant feedback is an important strategy to stimulate 
reflection in patients about their blood glucose goal and to engage them in healthy behaviours necessary for 
optimal health outcomes62.
Data privacy and security in mobile health interventions are vital to intervention development, relevance 
and acceptance of such technology63, therefore, health apps must be protected from security breaches. This was 
ensured in My Care Hub. The multi-stage usability evaluation method applied to My Care Hub have better pro-
pensity to capture the complete usability of a technology in comparison to a single method64,65. First stage of 
testing revealed important changes to the app design in order to improve the ease of access to user interface. 
Similar to our findings, participants in studies assessing the usability of mobile apps for diabetes self-management 
had commented positively on the performance and ease of navigation of the app65,66. Furthermore, good level of 
satisfaction reported by our participants in relation to the app’s graphics, layout and visual appeal has also been 
reported in previous studies65,67. End users saw value in the app as a tool to support diabetes self-management and 
expressed interest in continuing to use the app in the future.
Strengths and limitations. The strengths of this study include a full description of the development pro-
cess of My Care Hub - an app aimed at the Australian population with type 1 or type 2 diabetes as opposed to the 
scanty reports of only efficacy and effectiveness of diabetes apps within RCTs in the published literature19. In our 
systematic review of previous RCTs using a diabetes app as an intervention, none of the studies provided detailed 
information about their developmental process19. The need for full description of the intervention development 
strategy, including detailed explanation of how information gathered from users was used to guide the develop-
ment process has been met in our current study. Not only is the use of two distinct approaches to usability testing 
unique in providing effective development guide and strategies for future apps, the results from both phases also 
allow for identification of pertinent issues from a general and targeted populace of app users. Usability testing of 
the app at this stage and not later during feasibility testing, is essential for identifying improvement needs prior to 
full studies to secure future engagement with My Care Hub by patients with diabetes.
A limitation of this study is that the participants in the usability study may not be representative of the target 
population due to low sample size. Nonetheless, studies have shown that large sample sizes are not required in 
usability studies, as they do not propose inferential results. Therefore, the number of participants involved in 
the usability testing of My Care Hub in this study, may have been sufficient to identify usability issues in the app 
which may occur under conditions of regular use68. Another limitation is that only some of those who initially 
agreed to test the app eventually did so. This may have introduced a selection bias wherein only participants inter-
ested in the use of an app downloaded and signed into it and provided feedback. It is possible that we could have 
drawn different conclusion if all the initial participants had used the app. However, in reality, research outcomes 
are not free of either opinion or bias because they are highly subjective69. In addition, although, the app needs 
analysis results indicated that patients will like an app that reminds them of their self-management activities, cur-
rently My Care Hub app does not have this feature. This is because upon prioritization and consideration, we felt 
inclusion of a reminder feature might further increase the complexity of the app. In its’ present version, the app 
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entails a variety of features, therefore an addition of reminder feature (which ideally will be needed for each of the 
diabetes specific tasks) will definitely increase the app’s complexity. Studies have reported a significantly negative 
correlation between number of app features and ease of use70. Nonetheless, upon ensuring that the app remains 
user friendly, inclusion of a reminder feature is a possible consideration for our future research. Lastly, given that 
no data was collected about the specifics of participants’ android smartphone configurations, we were unable to 
assess the influence of such configuration on their responses to My Care Hub usability testing.
Future research. Future research includes pilot testing of My Care Hub as a key step for optimizing an 
intervention before its evaluation in a full randomized controlled trial71. This pilot testing will provide valuable 
information on users’ engagement, acceptability and preliminary efficacy72 as well as the development of future 
versions of the app (if required) and design of future trials73.
My Care Hub is currently only available for Australians on Android operating system. The decision to make 
the app Australia-specific was based on the differences in the guidelines for recommended blood glucose levels 
between countries. There was the need to focus resources on developing a native app that could as much as possi-
ble provide a better user experience instead of including additional country specific requirements. My Care Hub 
presents a proof of concept and can be developed for other nations in order to reach a wider proportion of users, 
but there will be the need to modify the Australia-specific features of the app before it could be used elsewhere.
conclusions
Detailed explanation of My Care Hub development was provided for future researchers to learn and understand 
the development process. My Care Hub has the potential to benefit Australians with types 1 and 2 diabetes in 
monitoring self-management activities. The app provides easy access to educational information which could 
enhance knowledge and motivate patients to perform self-management activities to improve glycemic control. 
An app such as My Care Hub developed based on the needs and preferences of its intended users maximizes the 
potential to enhance self-management.
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